These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Utility of bolus dynamic CT for the detection of hypervascular malignant hepatic tumors: mainly referring to the comparison with delayed phase contrast-enhanced CT]. Matsuda H; Abe K; Freeny PC Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Mar; 56(4):167-72. PubMed ID: 8992451 [TBL] [Abstract][Full Text] [Related]
25. [Optimal phase of dynamic CT for detecting hypervascular hepatocellular carcinoma: evaluation of double arterial phases]. Kajiya Y; Kamimura K; Jinguji M; Nakajo M; Tsuchimochi S; Sako K; Komorizono Y Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Apr; 65(2):99-104. PubMed ID: 15920968 [TBL] [Abstract][Full Text] [Related]
26. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens. Takayasu K; Muramatsu Y; Mizuguchi Y; Moriyama N; Ojima H Intervirology; 2004; 47(3-5):199-208. PubMed ID: 15383730 [TBL] [Abstract][Full Text] [Related]
27. [IIn-line X-ray phase-contrast imaging of human hepatocellular carcinoma microvasculature ex vivo]. Li B; Zhang Y; Cai L; Du G; Hou X; Shi H; Chen S Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):233-5. PubMed ID: 24919227 [No Abstract] [Full Text] [Related]
28. How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease: feasibility of contrast-enhanced ultrasound with a microbubble contrast agent. Yoshizumi H; Maruyama H; Okugawa H; Kobayashi S; Akiike T; Yoshikawa M; Ebara M; Yokosuka O; Matsutani S; Kondo F; Kamiyama N J Gastroenterol Hepatol; 2008 Oct; 23(10):1528-34. PubMed ID: 17944882 [TBL] [Abstract][Full Text] [Related]
29. Optimal scan timing for coronal enhancement of hypervascular hepatocellular carcinomas and correlation with tumor size: evaluation with four-phase CT hepatic arteriography. Miyamoto N; Sakurai Y; Nishimori H; Tsuji K; Kang JH; Maguchi H Radiat Med; 2005 Sep; 23(6):456-62. PubMed ID: 16389992 [TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Pompili M; Riccardi L; Semeraro S; Orefice R; Elia F; Barbaro B; Covino M; Grieco A; Gasbarrini G; Rapaccini GL Dig Liver Dis; 2008 Mar; 40(3):206-15. PubMed ID: 18054850 [TBL] [Abstract][Full Text] [Related]
31. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Kitao A; Zen Y; Matsui O; Gabata T; Nakanuma Y Radiology; 2009 Aug; 252(2):605-14. PubMed ID: 19703890 [TBL] [Abstract][Full Text] [Related]
32. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. Hyodo T; Murakami T; Imai Y; Okada M; Hori M; Kagawa Y; Kogita S; Kumano S; Kudo M; Mochizuki T Radiology; 2013 Feb; 266(2):480-90. PubMed ID: 23362095 [TBL] [Abstract][Full Text] [Related]
33. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Ueda K; Matsui O; Kawamori Y; Nakanuma Y; Kadoya M; Yoshikawa J; Gabata T; Nonomura A; Takashima T Radiology; 1998 Jan; 206(1):161-6. PubMed ID: 9423667 [TBL] [Abstract][Full Text] [Related]
34. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. Ito K; Fujita T; Shimizu A; Koike S; Sasaki K; Matsunaga N; Hibino S; Yuhara M AJR Am J Roentgenol; 2004 Sep; 183(3):699-705. PubMed ID: 15333358 [TBL] [Abstract][Full Text] [Related]
35. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. Bashir MR; Huang R; Mayes N; Marin D; Berg CL; Nelson RC; Jaffe TA J Magn Reson Imaging; 2015 Aug; 42(2):305-14. PubMed ID: 25371354 [TBL] [Abstract][Full Text] [Related]
36. Intraobserver and Interobserver Agreement in the Evaluation of Tumor Vascularization With Computed Tomography Perfusion in Cirrhotic Patients With Hepatocellular Carcinoma. Ippolito D; Casiraghi AS; Talei Franzesi C; Bonaffini PA; Fior D; Sironi S J Comput Assist Tomogr; 2016; 40(1):152-9. PubMed ID: 26484957 [TBL] [Abstract][Full Text] [Related]
37. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015 [TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma with nodule-in-nodule appearance: demonstration by contrast-enhanced coded phase inversion harmonic imaging. Zheng RQ; Zhou P; Kudo M Intervirology; 2004; 47(3-5):184-90. PubMed ID: 15383728 [TBL] [Abstract][Full Text] [Related]
39. Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma. Murakami T; Oi H; Hori M; Kim T; Takahashi S; Tomoda K; Narumi Y; Nakamura H AJR Am J Roentgenol; 1997 Jul; 169(1):131-5. PubMed ID: 9207512 [TBL] [Abstract][Full Text] [Related]
40. Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies. Kim KS; Lee JM; Kim SH; Kim KW; Kim SJ; Cho SH; Han JK; Choi BI Invest Radiol; 2010 Mar; 45(3):149-57. PubMed ID: 20142749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]